Insider Trading & Ownership of Joshua Silverman

Location
New York, NY
Summary
The estimated net worth of Joshua Silverman is at least $2,268,991 dollars as of 15 Apr 2026. Joshua Silverman is the Executive Chairman, Director of Q/C TECHNOLOGIES, INC. and owns shares of Q/C TECHNOLOGIES, INC. (QCLS) stock worth about $1.05M. Joshua Silverman is the Executive Chairman, Director of TAO Synergies Inc. and owns shares of TAO Synergies Inc. (TAOX) stock worth about $626.7K. Joshua Silverman is the CEO and President, Director of PharmaCyte Biotech, Inc. and owns shares of PharmaCyte Biotech, Inc. (PMCB) stock worth about $397.7K. Joshua Silverman is the Chief Executive Officer, Director of StableX Technologies, Inc. and owns shares of StableX Technologies, Inc. (SBLX) stock worth about $154.3K. Joshua Silverman is the Director of Petros Pharmaceuticals, Inc. and owns shares of Petros Pharmaceuticals, Inc. (PTPI) stock worth about $44.2K.
Signature
/s/ Joshua Silverman
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Joshua Silverman and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Joshua Silverman has 6 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,268,991.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Q/C TECHNOLOGIES, INC. ($1,046,142).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Joshua Silverman

FEMY Forms 3/4/5

FEMASYS INC

Relationship
Director
Holdings value
Past year net change
Change %
Report period
17 Mar 2026

Insider Transactions Reported by Joshua Silverman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .